NET PROFIT (x1000 SEK)
EMPLOYEES
TILT Biotherapeutics Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Financial expenses |
1,387
|
18
|
0 |
Earnings before taxes |
-13,317
|
-3,508
|
-837 |
Total assets |
39,310
|
16,754
|
3,016 |
Current assets |
38,966
|
16,543
|
2,217 |
Current liabilities |
1,148
|
639
|
247 |
Equity capital |
26,472
|
11,501
|
1,351 |
- share capital |
29
|
27
|
29 |
Employees (average) |
7
|
3
|
2 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
67.3%
|
68.6%
|
44.8% |
Turnover per employee | |||
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-30.3%
|
-20.8%
|
-27.8% |
Current ratio |
3394.3%
|
2588.9%
|
897.6% |
Return on equity (ROE) |
-50.3%
|
-30.5%
|
-62.0% |
Change turnover | |||
Change turnover % | |||
Chg. No. of employees |
4
|
1
|
0 |
Chg. No. of employees % |
133%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.